Alerts will be sent to your verified email
Verify Email
VENUSREM
|
Venus Remedies
|
Prevest Denpro
|
Sakar Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.87 % | 23.02 % | 9.28 % |
|
5yr average Equity Multiplier
|
1.32 | 1.16 | 1.75 |
|
5yr Average Asset Turnover Ratio
|
0.96 | 0.69 | 0.5 |
|
5yr Avg Net Profit Margin
|
6.91 % | 28.95 % | 10.38 % |
|
Price to Book
|
1.25 | 6.31 | 2.67 |
|
P/E
|
13.04 | 36.68 | 38.61 |
|
5yr Avg Cash Conversion Cycle
|
46.96 Days | 57.55 Days | -14.29 Days |
|
Inventory Days
|
75.64 Days | 26.01 Days | 46.75 Days |
|
Days Receivable
|
54.28 Days | 50.74 Days | 51.16 Days |
|
Days Payable
|
58.86 Days | 75.73 Days | 103.34 Days |
|
5yr Average Interest Coverage Ratio
|
396.11 | 75.33 | 5.43 |
|
5yr Avg ROCE
|
8.42 % | 30.18 % | 10.08 % |
|
5yr Avg Operating Profit Margin
|
10.14 % | 36.73 % | 24.06 % |
|
5 yr average Debt to Equity
|
0.08 | 0.02 | 0.47 |
|
5yr CAGR Net Profit
|
-6.01 % | 17.49 % | 3.94 % |
|
5yr Average Return on Assets
|
6.69 % | 19.63 % | 5.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
41.76 % | 73.6 % | 52.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -14.68 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Venus Remedies
|
Prevest Denpro
|
Sakar Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|